Last reviewed · How we verify

NCT06367582

Spine Bone Cements Outcomes - Post Market Follow-up

Recruiting now Last updated 9 September 2025
What this trial tests

trial testing Vertebroplasty (VP) in Vertebral Fracture in 500 participants. Currently enrolling.

Timeline
4 September 2019
Primary endpoint
4 September 2029
30 September 2039

Quick facts

Lead sponsorTeknimed
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment500
Start date4 September 2019
Primary completion4 September 2029
Estimated completion30 September 2039
Sites12 locations across Portugal, France, Ukraine, Spain

Drugs / interventions tested

Conditions studied

Sponsor

Teknimed

Who can join

18 and older, any sex, with Vertebral Fracture or Compression Fracture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A Post-Market Clinical Follow-Up (PMCF) Study to collect clinical data on safety and performance of all TEKNIMED Spine range of products: SPINEFIX, HIGH V+, OPACITY+ and F20 bone cements and mixing and injection systems, and all their private labels. TEKNIMED bone cements are legacy products, some marketed for more than 10 years. Their performance and safety have already been demonstrated by Post-Market Surveillance and previous clinical studies. The current Post-Market Clinical Follow-Up study aims to confirm these claims by collecting data in a "real-life" setting. The study is a retrospective and prospective global, single arm, non-controlled, multicentric, prospective observational study. Patients will be followed as per local standard medical care of the sites.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Vertebral Fracture

Currently open trials in the same condition.

Other Teknimed trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06367582.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing